Your browser doesn't support javascript.
loading
The efficacy and safety of caplacizumab in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura: an open-label phase 2/3 study.
Miyakawa, Yoshitaka; Imada, Kazunori; Ichikawa, Satoshi; Uchiyama, Hitoji; Ueda, Yasunori; Yonezawa, Akihito; Fujitani, Shigeki; Ogawa, Yoshiyuki; Matsushita, Tadashi; Asakura, Hidesaku; Nishio, Kenji; Suzuki, Kodai; Hashimoto, Yasuhiro; Murakami, Hidenori; Tahara, Sayaka; Tanaka, Tomoyuki; Matsumoto, Masanori.
Affiliation
  • Miyakawa Y; Department of Hematology, Saitama Medical University Hospital, Saitama, Japan.
  • Imada K; Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan.
  • Ichikawa S; Department of Hematology, Tohoku University Hospital, Sendai, Japan.
  • Uchiyama H; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Ueda Y; Department of Hematology/Oncology, Kurashiki Central Hospital, Kurashiki, Japan.
  • Yonezawa A; Department of Hematology, Kokura Memorial Hospital, Kitakyushu, Japan.
  • Fujitani S; Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine Hospital, Kawasaki, Japan.
  • Ogawa Y; Department of Hematology, Gunma University Hospital, Maebashi, Japan.
  • Matsushita T; Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Asakura H; Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan.
  • Nishio K; Department of General Medicine, Nara Medical University Hospital, Kashihara, Japan.
  • Suzuki K; Department of Hematology, Saitama Medical University Hospital, Saitama, Japan.
  • Hashimoto Y; Sanofi K.K., Tokyo, Japan.
  • Murakami H; Sanofi K.K., Tokyo, Japan.
  • Tahara S; Sanofi K.K., Tokyo, Japan.
  • Tanaka T; Sanofi K.K., Tokyo, Japan.
  • Matsumoto M; Department of Blood Transfusion Medicine, Nara Medical University, 840 Shijyo-Cho, Kashihara, Nara, 634-8522, Japan. mmatsumo@naramed-u.ac.jp.
Int J Hematol ; 117(3): 366-377, 2023 Mar.
Article in En | MEDLINE | ID: mdl-36427162

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Purpura, Thrombotic Thrombocytopenic / Single-Domain Antibodies Type of study: Prognostic_studies Limits: Adult / Humans Language: En Journal: Int J Hematol Journal subject: HEMATOLOGIA Year: 2023 Document type: Article Affiliation country: Japón

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Purpura, Thrombotic Thrombocytopenic / Single-Domain Antibodies Type of study: Prognostic_studies Limits: Adult / Humans Language: En Journal: Int J Hematol Journal subject: HEMATOLOGIA Year: 2023 Document type: Article Affiliation country: Japón